Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 29, 2015
0Patent Application Number
141366910
Date Filed
December 20, 2013
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.